3 months ago
1
With India’s nutraceutical assemblage projected to turn from $8 to $9 cardinal to $20 to $30 cardinal by 2030 astatine a CAGR of 15 to18%, the assemblage has imaginable to turn 10 times than the pharmaceutical industry, said Pritee Chaudhary, IRS, Regional Director, Food Safety and Standards Authority of India (FSSAI), West Region, Mumbai portion speaking astatine Vitafoods India amusement successful Mumbai connected Wednesday.
“India’s nutraceutical manufacture represents a strategical pillar for nation-building. Currently representing astir 2% of the planetary market, the sector’s semipermanent imaginable could surpass pharmaceuticals by astatine slightest tenfold, fixed nutraceuticals’ relation successful regular preventive healthcare done wellness supplements, probiotics, and prebiotics,” she said.
“India leverages its beardown pharmaceutical expertise, a consultative FSSAI regulatory framework, and a increasing manufacturing basal successful hubs similar Gujarat and Himachal Pradesh. With implicit 6 to 7 Free Trade Agreements (FTAs) successful spot with cardinal markets specified arsenic the UK, EU, USA, Mauritius, UAE, and Australia, coupled with rising accent connected research, molecule development, and technological validation, the manufacture is poised to standard responsibly and pb globally implicit the adjacent 5 years,” she emphasized.
Industry officials said India’s nutraceutical maturation stems from demographic and manner shifts, with science-backed nutrition powering preventive healthcare. By 2050, the aged colonisation volition scope 347 million, spurring request for clean-label functional foods supporting energy, cognition, and metabolic health.
Also arsenic the mediate people is investing successful regular wellness and obesity driving value absorption solutions, supplements person been blended into routines. These converging trends are shaping the maturation and aboriginal of the sector, they added.
Kaushik Desai, Secretary General, Health Foods and Dietary Supplements Association (HADSA), portion speaking astatine Vitafoods India said, “The planetary nutraceutical manufacture is projected to scope $919 cardinal by 2030, increasing astatine a CAGR of 7% crossed functional foods, dietary supplements and personalised nutrition. As the marketplace expands, stronger collaboration betwixt FSSAI and manufacture is captious to guarantee safety, quality, and regulatory compliance, alongside greater accent connected clinically validated, evidence-based products to reenforce user trust.”
“Rising request for sustainable, plant-based and clean-label solutions, coupled with the maturation of e-commerce and direct-to-consumer channels, is accelerating innovation. India’s biodiversity and accepted medicine practice supply a beardown instauration for globally competitory offerings, and with focused concern successful research, innovation and compliance, the assemblage tin importantly beforehand preventive healthcare access,” helium added.
Highlighting the translation of Indian botanical ingredients sector, Hitesh Patel, Joint Managing Director, K. Patel Phyto Extracts, said, “The botanical ingredients assemblage successful India is increasing done structured cultivation, husbandman partnerships, sustainable and integrated practices, and strict compliance with Japanese, European, and American regulatory standards.”
“Although an earlier 50% American tariff created impermanent pressure, the revised 18% complaint is expected to stabilise volumes successful the coming months, portion supplies to Europe stay steady. The manufacture has evolved from accepted ratio-based Ayurveda formulations to standardised extracts validated one, and it is present advancing toward clinically researched, scientifically validated ingredients,” helium added.
Yogesh Mudras, Managing Director, Informa Markets successful India, the organisers of Vitafoods India said, “India is entering a decisive decennary wherever nutrition volition specify the country’s wellness and productivity outcomes. As per capita disposable income is projected to attack Rs 2.5 lakh by 2030, consumers are consciously investing successful preventive health, personalised nutrition, and mundane wellness.”
“This displacement is being reinforced by nationalist initiatives specified arsenic the National Nutrition Strategy and a steadily evolving regulatory ecosystem nether FSSAI, creating a beardown instauration for liable manufacture growth. In this context, Vitafoods India 2025–2026 emerges arsenic much than an exhibition. It is simply a imaginativeness level wherever science, policy, and innovation align to alteration the nutraceutical assemblage to determination from intent to interaction and from home maturation to planetary leadership,” helium added.
Sandeep Gupta, Founder & Director of Expert Nutraceutical Advocacy Council (ENAC) said, “India’s nutraceutical assemblage is astatine a defining signifier of growth. While our stock successful the planetary marketplace remains modest, the state possesses beardown manufacturing capabilities, affluent biodiversity and heavy expertise successful earthy ingredients and phyto extracts that presumption america for acold greater planetary relevance.”
“The precedence present is deeper collaboration crossed industry, academia and authorities to fortify quality, innovation and home worth creation. By bringing unneurotic manufacture leaders and policymakers to code opportunities and regulatory pathways, we tin illustration a structured roadmap for sustainable and credible growth,” helium said.
